The collective clinical research system needs to be thoroughly reconsidered: designed with end users in mind; built to earn trust in research aims and execution; able to maximize the likelihood of engaging the targets—people and communities—stakeholders need to reach. We need to disrupt the paradigm, taking a person-centered, data-driven approach to engage the broadest population of Americans in opportunities to take part in research. New players entering the research enterprise are bringing unique abilities to generate participant and community insights that can influence research objectives, design, and adoption; define, track, and improve participants’ journeys through the research process; measure and drive accountability for outcomes that matter to participants and communities as well as research stakeholders; and reframe research as an opportunity for inclusion rather than a requirement for diversity.

Moderator

Michelle McMurry-Heath

Founder and CEO, Biotechquity Clinical

Speakers

Silas Buchanan

CEO, OurHealthyCommunity

Martin Landray

CEO, Protas

Susan Monarez

Deputy Director, Advanced Research Projects Agency for Health

Fabian Sandoval

President and CEO, Emerson Clinical Research Institute

Andrew Trister

Chief Medical and Scientific Officer, Verily Life Sciences